2020 Virtual Annual Meeting

10/26: CONCURRENT SESSION: Prescription Drug Importation, Legal Limits and Remedies

October 26, 2020 9:00 AM to 10:30 AM

Location

Virtual - all times are eastern daylight time

Credits

90 CLE Minutes


 

Topic:

CONCURRENT SESSION: Prescription Drug Importation, Legal Limits and Remedies 



Moderator

Sara Koblitz, Hyman Phelps & McNamara, Washington, DC

Speakers:

Alison Kessler, LifeSci Consulting, LLC, 
Josephine Young, Paul Weiss Rifkind Wharton & Garrison, LLP, New York, NY
Craig Svoboda, Alvotech USA Inc., Arlington, VA



A joint program of the Food & Drug, IP Transactions, ITC, and Biotechnology Committees

Speakers

  • Svoboda, C Svoboda, Craig

    Alvotech | Global Head Intellectual Property

  • Young, Josephine200 Young, Josephine

    Paul Weiss | Counsel

    A counsel in the Litigation Department and member of the Intellectual Property Litigation practice group, Josephine Young focuses her practice on patent litigation matters. Prior to joining the firm, Ms. Young worked as a patent examiner with the U.S. Patent and Trademark Office where she examined patents in the biotechnology, pharmaceutical and chemical arts, and as a patent agent where she filed and prosecuted U.S. and foreign patents and assisted in interference and opposition proceedings.
  • kessler, allison200 Kessler, Alison

    LifeSci Consulting

  • Koblitz, Sara200 Koblitz, Sara W.

    Hyman, Phelps & McNamara | Associate

    Sara W. Koblitz advises FDA-regulated clients on a range of issues with a particular focus on Hatch-Waxman patent and exclusivity, biosimilars, and the Orange Book. She helps drug and device manufacturers in various stages of product development and guides clients through the applicable regulatory requirements with respect to applications and submissions, device classification, potential exclusivities, promotional issues, and post-marketing requirements.